The Antidiabetic PPAR&ggr; Ligands: An Update on Compounds in Development

Publisher： Bentham Science Publishers

E-ISSN： 1875-6107|2|1|33-47

ISSN： 1568-0134

Source： Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol.2, Iss.1, 2002-03, pp. : 33-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PPAR&ggr; in Angiogenesis and Vascular Development

By  

Current Angiogenesis, Vol. 1, Iss. 3, 2012-09 ,pp. : 192-205

Bentham Science Publishers

Access to resources Recommend Favorite

&ggr;-Secretase-Regulated Signaling Pathways, such as Notch Signaling, Mediate the Differentiation of Hematopoietic Stem Cells, Development of the Immune System, and Peripheral Immune Responses

By  

Current Stem Cell Research & Therapy, Vol. 6, Iss. 2, 2011-06 ,pp. : 131-141

Bentham Science Publishers

Access to resources Recommend Favorite

A&bgr; Metallobiology and the Development of Novel Metal-Protein Attenuating Compounds (MPACs) for Alzheimer's Disease

By  

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 3, Iss. 4, 2003-12 ,pp. : 309-315

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor-&ggr; in Vascular Biology

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 7, Iss. 2, 2007-06 ,pp. : 109-117

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor-&ggr; (PPAR-&ggr;) Ligands: Novel Pharmacological Agents in the Treatment of Ischemia Reperfusion Injury

By  

Current Molecular Medicine, Vol. 8, Iss. 6, 2008-01 ,pp. : 562-579

Bentham Science Publishers

Access to resources Recommend Favorite